Group One Trading, L.P. Chembio Diagnostics, Inc. Transaction History

Group One Trading, L.P.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	BUY	$0.2 - $0.33 $1,525 - $2,517	7,628 Added 35.17%	29,315 $6,000
Q3 2022 Nov 09, 2022	BUY	$0.35 - $1.1 $907 - $2,853	2,594 Added 13.59%	21,687 $8,000
Q2 2022 Aug 11, 2022	SELL	$0.45 - $0.8 $1,270 - $2,259	-2,824 Reduced 12.88%	19,093 $12,000
Q1 2022 May 12, 2022	BUY	$0.66 - $1.23 $66 - $123	100 Added 0.46%	21,917 $18,000
Q4 2021 Feb 11, 2022	SELL	$1.09 - $2.55 $53,174 - $124,399	-48,784 Reduced 69.1%	21,817 $25,000
Q3 2021 Nov 12, 2021	BUY	$2.06 - $5.34 $145,438 - $377,009	70,601 New	70,601 $177,000
Q2 2021 Aug 10, 2021	SELL	$2.88 - $5.64 $17,386 - $34,048	-6,037 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$3.4 - $7.97 $128,693 - $301,672	-37,851 Reduced 86.24%	6,037 $21,000
Q4 2020 Feb 10, 2021	BUY	$4.11 - $7.51 $94,612 - $172,880	23,020 Added 110.31%	43,888 $208,000
Q3 2020 Nov 12, 2020	SELL	$3.28 - $5.93 $40,075 - $72,452	-12,218 Reduced 36.93%	20,868 $101,000
Q2 2020 Aug 13, 2020	BUY	$3.18 - $15.54 $105,213 - $514,156	33,086 New	33,086 $108,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.